-+ 0.00%
-+ 0.00%
-+ 0.00%

Atossa Therapeutics Q2 EPS $(0.95) Beats $(1.02) Estimate

Benzinga·08/07/2026 13:30:58
Listen to the news
Atossa Therapeutics (NASDAQ:ATOS) reported quarterly losses of $(0.95) per share which beat the analyst consensus estimate of $(1.02) by 6.86 percent. This is a 171.43 percent decrease over losses of $(0.35) per share from the same period last year.